Who Runs the World? Highlighting Research on Women and Girls With Bleeding Disorders - HHT in the News

Published on December 14, 2023

Abstract featuring HHT pulled into ASH Daily News article highlighting women and girls with bleeding disorders

 

Who Runs the World? Highlighting Research on Women and Girls with Bleeding Disorders

 

Ellen Zhang, MD from Stanford, in collaboration with Vanderbilt University and Mass General Hospital, presented work analyzing the impact of inherited bleeding disorders HHT and VWS on women to determine morbidity. The authors concluded HHT may be the most clinically significant and morbid inherited bleeding disorder among women. This work makes the case for increased funding and attention toward HHT to mitigate the gender inequality observed. 

 

Read the Abstract Here!

 

Thank you, team, for the work on an important and not well-studied area within HHT. 

 

Other news

Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT

December 9, 2023
A new study from the Brain Vascular Malformation Consortium (BVMC) HHT Investigator Group - Summarized by Cassi FridayThe General Question: Are kids the same as adults in terms of brain vascular malformations related to HHT? The Problem: Before this study, there was not a lot of information published looking at brain vascular malformations in children, the symptoms these malformations cause, their

PATH-HHT, a Double-Blind, Randomized, Placebo-Controlled Trial in Hereditary Hemorrhagic Telangiectasia Demonstrates That Pomalidomide Reduces Epistaxis and Improves Quality of Life

December 14, 2023
Late Breaking Abstract: PATH-HHT STUDY Click above to read the late-breaking abstract submission to the American Society of Hematology Conference in December 2023. This abstract was featured as an oral presentation and details the outcomes of the recently concluded NIH-supported clinical trial 'Pomalidomide for the Treatment of Bleeding in HHT (PATH-HHT)'.  Find more information on the trial here.